--------- PRESS RELEASE ---------

Paris, December 2, 2015

Danone invests €240 million in new facility to capitalize on growing demand for its Early Life Nutrition brands

Danone today announced that it is investing €240 million to build a new plant for its Early Life Nutrition business. With this investment, Danone will capitalize on strong and growing demand for its international early life nutrition brands, including Aptamil and Nutrilon, for both standard and specialized products. The state-of-the-art facility will be built in Cuijk in the Netherlands, and will start production in late 2017.

This new plant is Danone's largest investment in its European production capabilities, and will double its capacity in the Netherlands. Output will be exported to more than 80 countries worldwide.

Felix Martin Garcia, Executive Vice President of the Danone Nutricia Early Life Nutrition division said: "Building our new production plant in Cuijk is a major step for Danone and Nutricia. It will give us the capacity we need to meet rising demand for our early life nutrition products, and is consistent with our 2020 roadmap calling for strong, profitable and sustainable growth. We are also delighted to be making this investment in the Netherlands, where our Nutricia brand has had a proud heritage stretching back over more than 100 years."

The Cuijk location was chosen to capitalize on the expert know-how of current staff, and for the site's proximity to Danone's Research & Development center in Utrecht, which is the company's global hub for research dedicated to early life nutrition and advanced medical nutrition.

The new facility incorporates state-of-the-art technologies and will meet Danone's targets for sustainability, offering very high energy efficiency and complying with the strictest CO2 emission standards.

About Danone
Dedicated to bringing health through food to as many people as possible, Danone is a leading global food company built on four business lines: Fresh Dairy Products, Early Life Nutrition, Waters and Medical Nutrition. Through its mission and its dual commitment to business success and social progress, the company aims to create shared value for all of its stakeholders-its 100,000 employees, consumers, customers, suppliers and shareholders.
Present in over 130 markets, the company generated sales of €21.1 billion in 2014, with more than half in emerging countries. Danone's brand portfolio includes both international brands (Activia, Actimel, Danette, Danonino, Danio, Evian, Volvic, Nutrilon/Aptamil, Nutricia) and local brands (Prostokvashino, Aqua, Bonafont, Mizone, Blédina, Cow & Gate, Dumex).
Listed on Euronext Paris and on the OTCQX market via an ADR (American Depositary Receipt) program, Danone is a component stock of leading social responsibility indexes including the Dow Jones Sustainability Indexes, Vigeo and the Ethibel Sustainability Index. Danone is also ranked no. 1 in the 2013 ATNI index.


DANONE - ELN:
http://hugin.info/143411/R/1970735/720528.pdf



This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DANONE via Globenewswire

HUG#1970735